286 related articles for article (PubMed ID: 22698403)
1. ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21.
O'Brien CA; Kreso A; Ryan P; Hermans KG; Gibson L; Wang Y; Tsatsanis A; Gallinger S; Dick JE
Cancer Cell; 2012 Jun; 21(6):777-92. PubMed ID: 22698403
[TBL] [Abstract][Full Text] [Related]
2. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
3. ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis.
Hong SH; Lee JH; Lee JB; Ji J; Bhatia M
J Cell Sci; 2011 May; 124(Pt 9):1445-52. PubMed ID: 21486943
[TBL] [Abstract][Full Text] [Related]
4. Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer.
Shuno Y; Tsuno NH; Okaji Y; Tsuchiya T; Sakurai D; Nishikawa T; Yoshikawa N; Sasaki K; Hongo K; Tsurita G; Sunami E; Kitayama J; Tokunaga K; Takahashi K; Nagawa H
J Surg Res; 2010 Jun; 161(1):76-82. PubMed ID: 19515385
[TBL] [Abstract][Full Text] [Related]
5. The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.
Manrique I; Nguewa P; Bleau AM; Nistal-Villan E; Lopez I; Villalba M; Gil-Bazo I; Calvo A
Cancer Lett; 2015 Jan; 356(2 Pt B):899-909. PubMed ID: 25449776
[TBL] [Abstract][Full Text] [Related]
6. Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B.
Sharma P; Patel D; Chaudhary J
Cancer Med; 2012 Oct; 1(2):187-97. PubMed ID: 23342268
[TBL] [Abstract][Full Text] [Related]
7. [Expression of Id1 and Id3 in endometrial carcinoma and their roles in regulating biological behaviors of endometrial carcinoma cells in vitro].
Sun L; Li X; Liu G
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):812-8. PubMed ID: 23803189
[TBL] [Abstract][Full Text] [Related]
8. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
Jiang J; Zhang Y; Chuai S; Wang Z; Zheng D; Xu F; Zhang Y; Li C; Liang Y; Chen Z
Oncogene; 2012 Feb; 31(6):671-82. PubMed ID: 21743497
[TBL] [Abstract][Full Text] [Related]
9. Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells.
Ohata H; Ishiguro T; Aihara Y; Sato A; Sakai H; Sekine S; Taniguchi H; Akasu T; Fujita S; Nakagama H; Okamoto K
Cancer Res; 2012 Oct; 72(19):5101-10. PubMed ID: 23002207
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids.
Lobjois V; Frongia C; Jozan S; Truchet I; Valette A
Eur J Cancer; 2009 Sep; 45(13):2402-11. PubMed ID: 19553104
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.
Strong N; Millena AC; Walker L; Chaudhary J; Khan SA
Prostate; 2013 May; 73(6):624-33. PubMed ID: 23060149
[TBL] [Abstract][Full Text] [Related]
12. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
13. Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer.
Tsuchiya T; Okaji Y; Tsuno NH; Sakurai D; Tsuchiya N; Kawai K; Yazawa K; Asakage M; Yamada J; Yoneyama S; Kitayama J; Osada T; Watanabe T; Tokunaga K; Takahashi K; Nagawa H
Cancer Sci; 2005 Nov; 96(11):784-90. PubMed ID: 16271072
[TBL] [Abstract][Full Text] [Related]
14. Role of p21 as a determinant of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane response in human HCT-116 colon carcinoma cells.
Wang JJ; Hung HF; Huang ML; Lee HJ; Chern YT; Chang YF; Chi CW; Hsu YC
Oncol Rep; 2012 Feb; 27(2):529-34. PubMed ID: 22076474
[TBL] [Abstract][Full Text] [Related]
15. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase Cα signaling regulates inhibitor of DNA binding 1 in the intestinal epithelium.
Hao F; Pysz MA; Curry KJ; Haas KN; Seedhouse SJ; Black AR; Black JD
J Biol Chem; 2011 May; 286(20):18104-17. PubMed ID: 21454537
[TBL] [Abstract][Full Text] [Related]
17. The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis.
Ullmann P; Rodriguez F; Schmitz M; Meurer SK; Qureshi-Baig K; Felten P; Ginolhac A; Antunes L; Frasquilho S; Zügel N; Weiskirchen R; Haan S; Letellier E
Cancer Res; 2018 Jul; 78(14):3793-3808. PubMed ID: 29748374
[TBL] [Abstract][Full Text] [Related]
18. Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin.
Langenfeld E; Deen M; Zachariah E; Langenfeld J
Mol Cancer; 2013 Oct; 12(1):129. PubMed ID: 24160469
[TBL] [Abstract][Full Text] [Related]
19. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.
Asirvatham AJ; Schmidt MA; Chaudhary J
Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]